Switching from dulaglutide to tirzepatide improves HbA1c reduction in type 2 diabetes

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with escalating treatment with dulaglutide, according to a study published online April 4 in the Annals of Internal Medicine to coincide with the Internal Medicine Meeting, the annual meeting of the American College of Physicians, held from April 3 to 5 in New Orleans.
Read More

Survey shows patients with diabetes who follow doctor’s advice more likely to undergo diabetic retinopathy examinations

Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice guidelines for diabetes recommend that individuals undergo a fundus examination at least once a year to screen for diabetic retinopathy. However, previous studies indicate that fewer than half of individuals with diabetes in Japan undergo regular fundus examinations.
Read More
Top